These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23929033)

  • 1. On representative and illustrative comparisons with real data in bioinformatics: response to the letter to the editor by Smith et al.
    Boulesteix AL
    Bioinformatics; 2013 Oct; 29(20):2664-6. PubMed ID: 23929033
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to letter to the editor by Dr Wages et al.
    Hirakawa A; Matsui S
    Stat Med; 2014 May; 33(12):2159-60. PubMed ID: 24797320
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to letter to the editor from Chappelle, Spence, and Tury concerning Wolf et al. 2016: Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water. 2016, Crit. Rev. Toxicol. Vol 46: 43-53.
    Wolf DC; Embry MR
    Crit Rev Toxicol; 2016 Nov; 46(10):913-914. PubMed ID: 27805461
    [No Abstract]   [Full Text] [Related]  

  • 4. Answer to the Letter to the Editor of A. Piazzolla et al. concerning, "The Surgical Algorithm for the AOSpine, Thoracolumbar Spine Injury Classification System" by A. R. Vaccaro et al.; Eur Spine J (2016); 25(4):1087-1094.
    Vaccaro AR; Schroeder GD; Kepler CK; Oner FC; Vialle LR; Kandziora F; Koerner JD; Kurd MF; Reinhold M; Schnake KJ; Chapman J; Aarabi B; Fehlings MG; Dvorak MF
    Eur Spine J; 2017 Aug; 26(8):2216-2217. PubMed ID: 28646453
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the Editor Concerning "An Evidence-Based Staging System for Mucosal Melanoma: A Proposal," by Smith, Henry et al.
    Guo J; Balch CM
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):626-627. PubMed ID: 36255514
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter in response to 'The role of research for advanced practitioners'.
    Bolderston A; Harnett N; Lewis D; Smoke M
    J Med Radiat Sci; 2015 Dec; 62(4):292-3. PubMed ID: 27512576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the Editor concerning "The surgical algorithm for the AOSpine thoracolumbar spine injury classification system" by A. R. Vaccaro et al. Eur Spine J (2016);25(4):1087-1094.
    Piazzolla A; Solarino G; Moretti B
    Eur Spine J; 2017 Aug; 26(8):2214-2215. PubMed ID: 28597299
    [No Abstract]   [Full Text] [Related]  

  • 8. Multi-subject search correctly identifies causal connections and most causal directions in the DCM models of the Smith et al. simulation study.
    Ramsey JD; Hanson SJ; Glymour C
    Neuroimage; 2011 Oct; 58(3):838-48. PubMed ID: 21745580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
    Choi W; McConkey D
    Eur Urol; 2018 Apr; 73(4):e104-e105. PubMed ID: 29174465
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the editor concerning "320-slice CT neuroimaging: initial clinical experience and image quality evaluation" (Siebert E et al: Br J Radiol 2009;82:561-70).
    Siebert E; Bohner G; Dewey M; Hoffmann KT; Mews J; Engelken F; Bauknecht HC; Diekmann C; Masuhr F; Klingebiel R
    Br J Radiol; 2009 Jul; 82(979):615. PubMed ID: 19541946
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to the Waalkes et al., Letter to the editor concerning our "letter to the editor, Re: Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human relevant doses, Waalkes et al., Arch Toxicol, 2014".
    Cohen SM; Arnold LL; Klaunig JE; Goodman JI
    Arch Toxicol; 2015 Nov; 89(11):2167-8. PubMed ID: 26449479
    [No Abstract]   [Full Text] [Related]  

  • 12. Response letter to the Editor: In reference to the recent Letter to the Editor by Caneiro et al., 2016, regarding 'Low back pain misdiagnosis or missed diagnosis: Core principles'.
    Monie AP; Fazey PJ; Singer KP
    Musculoskelet Sci Pract; 2017 Apr; 28():e85. PubMed ID: 27771335
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Lei Kang, Lugang Huang and Jingti Zhang's Letter to the Editor re: Omar Fahmy, Mohd Ghani Khairul-Asri, Christian Schwentner, et al. Algorithm for Optimal Urethral Coverage in Hypospadias and Fistula Repair: A Systematic Review. Eur Urol 2016;70:293-8.
    Gakis G; Fahmy O
    Eur Urol; 2017 May; 71(5):e155-e156. PubMed ID: 27916203
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome.
    Tierney E; Nwokoro NA; Kelley RI
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):131-4. PubMed ID: 10899806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editor's note concerning letter to the editor by DE Roth and response to letter to the editor by V Bhatia et al.
    Shetty PS
    Eur J Clin Nutr; 2010 Aug; 64(8):914. PubMed ID: 20683451
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter in response to the letter to the editor of archives of toxicology by Woegerbauer et al. (2016).
    Wilhelm R; Kohl C; Schiemann J; Steinberg P
    Arch Toxicol; 2016 Dec; 90(12):3133-3137. PubMed ID: 27709271
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods for Predicting Warfarin Dose Requirements.
    Saffian SM; Wright DF; Roberts RL; Duffull SB
    Ther Drug Monit; 2015 Aug; 37(4):531-8. PubMed ID: 25549208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reclassification of Xanthomonas campestris pv. citri (ex Hasse 1915) Dye 1978 forms A, B/C/D, and E as X. smithii subsp. citri (ex Hasse) sp. nov. nom. rev. comb. nov., X. fuscans subsp. aurantifolii (ex Gabriel 1989) sp. nov. nom. rev. comb. nov., and X. alfalfae subsp. citrumelo (ex Riker and Jones) Gabriel et al., 1989 sp. nov. nom. rev. comb. nov.; X. campestris pv malvacearum (ex smith 1901) Dye 1978 as X. smithii subsp. smithii nov. comb. nov. nom. nov.; X. campestris pv. alfalfae (ex Riker and Jones, 1935) dye 1978 as X. alfalfae subsp. alfalfae (ex Riker et al., 1935) sp. nov. nom. rev.; and "var. fuscans" of X. campestris pv. phaseoli (ex Smith, 1987) Dye 1978 as X. fuscans subsp. fuscans sp. nov.
    Schaad NW; Postnikova E; Lacy GH; Sechler A; Agarkova I; Stromberg PE; Stromberg VK; Vidaver AK
    Syst Appl Microbiol; 2005 Aug; 28(6):494-518. PubMed ID: 16104350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to Giandomenico Roviello, Daniele Generali, and Roberto Petrioli's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.
    de Bono JS
    Eur Urol; 2017 Feb; 71(2):e56. PubMed ID: 27544577
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to Letter to the Editor: HbA1c as a screening tool for cystic fibrosis related diabetes: Response to letters by Widger et al. and Schnyder et al.
    Burgess JC; Bridges N; Winston B; Gyi KM; Hodson ME; Bilton D; Simmonds NJ
    J Cyst Fibros; 2016 Mar; 15(2):265-6. PubMed ID: 26711098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.